Effect of Imatinib Mesylate in a Patient with a Metastatic Gastrointestinal Stromal Tumor with a c-kit Mutation in Exon 11.

MLA

Keisuke Kubota, et al. “Effect of Imatinib Mesylate in a Patient with a Metastatic Gastrointestinal Stromal Tumor with a C-Kit Mutation in Exon 11.” Digestive Diseases & Sciences, vol. 52, no. 7, July 2007, pp. 1725–29. EBSCOhost, https://doi.org/10.1007/s10620-006-9092-6.

APA

Keisuke Kubota, Atom Katayama, Yutarou Takeshita, Koji Nozaki, Tetsuya Ueda, Kazuhiro Imamura, Naoki Hiki, Sachiyo Nomura, Michio Kaminishi, & Ken-Ichi Mafune. (2007). Effect of Imatinib Mesylate in a Patient with a Metastatic Gastrointestinal Stromal Tumor with a c-kit Mutation in Exon 11. Digestive Diseases & Sciences, 52(7), 1725–1729. https://doi.org/10.1007/s10620-006-9092-6

Chicago

Keisuke Kubota, Atom Katayama, Yutarou Takeshita, Koji Nozaki, Tetsuya Ueda, Kazuhiro Imamura, Naoki Hiki, Sachiyo Nomura, Michio Kaminishi, and Ken-Ichi Mafune. 2007. “Effect of Imatinib Mesylate in a Patient with a Metastatic Gastrointestinal Stromal Tumor with a C-Kit Mutation in Exon 11.” Digestive Diseases & Sciences 52 (7): 1725–29. doi:10.1007/s10620-006-9092-6.